IBDEI0CE ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5670,1,2,0)
 ;;=2^96375
 ;;^UTILITY(U,$J,358.3,5670,1,3,0)
 ;;=3^Ther/Proph/Diag Inj,IV Push Ea Addl
 ;;^UTILITY(U,$J,358.3,5671,0)
 ;;=96372^^28^376^10^^^^1
 ;;^UTILITY(U,$J,358.3,5671,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5671,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,5671,1,3,0)
 ;;=3^Ther/Proph/Diag Inj,SC/IM
 ;;^UTILITY(U,$J,358.3,5672,0)
 ;;=99281^^29^377^1
 ;;^UTILITY(U,$J,358.3,5672,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5672,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,5672,1,2,0)
 ;;=2^99281
 ;;^UTILITY(U,$J,358.3,5673,0)
 ;;=99282^^29^377^2
 ;;^UTILITY(U,$J,358.3,5673,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5673,1,1,0)
 ;;=1^Expanded Problem Focus,Low
 ;;^UTILITY(U,$J,358.3,5673,1,2,0)
 ;;=2^99282
 ;;^UTILITY(U,$J,358.3,5674,0)
 ;;=99283^^29^377^3
 ;;^UTILITY(U,$J,358.3,5674,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5674,1,1,0)
 ;;=1^Expanded Problem Focus,Mod
 ;;^UTILITY(U,$J,358.3,5674,1,2,0)
 ;;=2^99283
 ;;^UTILITY(U,$J,358.3,5675,0)
 ;;=99284^^29^377^4
 ;;^UTILITY(U,$J,358.3,5675,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5675,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,5675,1,2,0)
 ;;=2^99284
 ;;^UTILITY(U,$J,358.3,5676,0)
 ;;=99285^^29^377^5
 ;;^UTILITY(U,$J,358.3,5676,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5676,1,1,0)
 ;;=1^Comprehensive
 ;;^UTILITY(U,$J,358.3,5676,1,2,0)
 ;;=2^99285
 ;;^UTILITY(U,$J,358.3,5677,0)
 ;;=99211^^29^378^1
 ;;^UTILITY(U,$J,358.3,5677,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5677,1,1,0)
 ;;=1^Nursing Visit (NO MD Seen)
 ;;^UTILITY(U,$J,358.3,5677,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,5678,0)
 ;;=99291^^29^379^1
 ;;^UTILITY(U,$J,358.3,5678,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5678,1,1,0)
 ;;=1^Critical Care,1st Hr
 ;;^UTILITY(U,$J,358.3,5678,1,2,0)
 ;;=2^99291
 ;;^UTILITY(U,$J,358.3,5679,0)
 ;;=99292^^29^379^2
 ;;^UTILITY(U,$J,358.3,5679,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5679,1,1,0)
 ;;=1^Critical Care,Ea Addl 30 Min
 ;;^UTILITY(U,$J,358.3,5679,1,2,0)
 ;;=2^99292
 ;;^UTILITY(U,$J,358.3,5680,0)
 ;;=B18.2^^30^380^27
 ;;^UTILITY(U,$J,358.3,5680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5680,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,5680,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,5680,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,5681,0)
 ;;=C44.99^^30^380^51
 ;;^UTILITY(U,$J,358.3,5681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5681,1,3,0)
 ;;=3^Skin Cancer,Unspec
 ;;^UTILITY(U,$J,358.3,5681,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,5681,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,5682,0)
 ;;=E11.9^^30^380^16
 ;;^UTILITY(U,$J,358.3,5682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5682,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,5682,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,5682,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,5683,0)
 ;;=E11.40^^30^380^17
 ;;^UTILITY(U,$J,358.3,5683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5683,1,3,0)
 ;;=3^Diabetes Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,5683,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,5683,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,5684,0)
 ;;=E78.2^^30^380^28
 ;;^UTILITY(U,$J,358.3,5684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5684,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,5684,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,5684,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,5685,0)
 ;;=E78.5^^30^380^29
 ;;^UTILITY(U,$J,358.3,5685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5685,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,5685,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,5685,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,5686,0)
 ;;=E66.3^^30^380^45
